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Malignancy-associated hemophagocytosis in children
Çocuklarda malignite ile iliýkili hemofagositoz
To the Editor,
Hemophagocytic syndrome (HPS) is a clinical entity 
characterized by prolonged fever, splenomegaly and 
cytopenias. Secondary HPS can be related to underlying 
conditions including malignancies. HPS in association with 
malignant diseases, especially lymphoma, is a well-known 
entity in adults but is rare in children [1-5]. We report three 
cases of malignancies associated with HPS according to 
the criteria of hemophagocytic lymphohistiocytosis (HLH)-
2004 [6]. All the clinical and laboratory findings of the 
patients are summarized in Table 1. 
Case 1
An 11-year-old patient was admitted with 
cervical lymphadenopathy. Bone marrow aspiration 
was normal, and the patient was diagnosed as 
anaplastic large cell lymphoma by lymph node 
biopsy. One week after initial low-dose chemotherapy, 
fever, hepatosplenomegaly, bicytopenia, and clinical 
findings of disseminated intravascular coagulopathy 
(DIC) developed. In spite of supportive treatment, clinical 
findings worsened. Because of myelosuppression, which 
was unexpected from chemotherapy, hyperbilirubinemia, 
hypertriglyceridemia, and hypofibrinogenemia, the patient 
was thought to have HPS. Bone marrow aspirations 
showed hemophagocytosis and chemotherapy was 
restarted. Clinical and laboratory findings had improved 
in 10 days. 
Case 2
A 15-year-old patient was hospitalized with swellings 
over her face and neck, fever, hepatosplenomegaly, 
pancytopenia, and hypertriglyceridemia. She was 
diagnosed as subcutaneous panniculitis-like T-cell 
lymphoma by skin biopsy. Hemophagocytosis was 
found in bone marrow aspiration and inside tumor 
lesions. During the first week of treatment, the fever 
resolved, and regression of lesions and improvement in 
hematological findings were noted. 
Case 3
A 10-year-old patient admitted with fever, purpuric 
lesions, hepatomegaly, lymphadenopathies, and 
pancytopenia. Skin biopsy was compatible with Kaposi 
sarcoma, and inguinal lymph node biopsy was reported 
as Castleman disease. Bone marrow aspiration was 
hypocellular. In the second week of chemotherapy, 
there was an improvement in clinical and laboratory 
findings. Treatment was ceased for two weeks because 
the drug could not be provided. Fever, hepatomegaly 
and pancytopenia were observed again with addition 
of hyperferritinemia. Chemotherapy was restarted. 
Repeated bone marrow aspirations revealed dysplastic 
changes and hemophagocytosis. Hemophagocytosis 
disappeared in bone marrow in the first month of 
treatment. Unfortunately, her condition failed to improve 
and she died due to respiratory failure. 
In conclusion, although rare, HPS may manifest 
secondary to malignancies. In hemophagocytosis, at 
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Phone: +90 212 231 22 09 E-mail: sdvural@yahoo.comthe time of diagnosis or during the treatment of malignancies, 
it is not easy to establish whether clinical findings are due to 
malignancy, chemotherapy or hemophagocytosis. Thus, if 
there is an unexpected or prolonged myelosuppression in 
oncology patients presenting with fever and DIC findings, HPS 
should be included in the differential diagnosis. 
Conflict of interest
No author of this paper has a conflict of interest, includingspe-
cific financial interests, relationships, and/or affiliations relevant to 
the subject matter or materials included in this manuscript.
References
1.  Janka G, Elinder G, Imashuku S, Schneider M, Henter JI. Infection-
and malignancy-associated hemophagocytic syndromes: 
secondary hemophagocytic lymphohistiocytosis. Hematol Oncol 
Clin North Am. 1998; 12: 435-44.
2.  Janka GE. Haemophagocytic lymphohistiocytosis. Hematology. 
2005; 10: 104-7.
3. Wong KF, Chan JK. Reactive hemophagocytic syndrome-a 
clinicopathologic study of 40 patients in an Oriental population. 
Am J Med. 1992; 93: 177-80.
4.  Takahashi N, Chubachi A, Kume M, Hatano Y, Komatsuda A, 
Kawabata Y, Yanagiya N, Ichikawa Y, Miura AB, Miura I. A 
clinical analysis of 52 adult patients with hemophagocytic 
syndrome: the prognostic significance of the underlying diseases. 
Int. J. Hematol. 2001; 74: 209-13. 
5. Miyahara M, Sano M, Shibata K, Matsuzaki M, Ibaraki K, 
Shimamoto Y, Tokunaga O. B-cell lymphoma-associated 
hemophagocytic syndrome: clinicopathological characteristics. 
Ann Hematol. 2000; 79: 378-88. 
6. Henter JI, Horne A, Aricò M, Egeler RM, Filipovich AH, 
Imashuku S, Ladisch S, McClain K, Webb D, Winiarski J, Janka 
G. HLH-2004: Diagnostic and therapeutic guidelines for 
hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 
2007; 48: 124-31. 
Vural et al.
Malignancy hemophagocytosis Turk J Hematol 2010; 27: 49-50 50
Table 1. Clinical and laboratory manifestations of  three patients with concomitant  malignancies
Clinical/Laboratory Findings  Patient 1  Patient 2  Patient 3
Fever +  +  +
Splenomegaly +  +  -
Hepatomegaly +  +  +
Lymphadenopathy +  -  +
Rash -  -  -
Neurological signs  -  -  -
Anemia +  +  +
Thrombocytopenia +  +  +
Neutropenia +  +  +
Hypertriglyceridemia +  +  -
Hypofibrinogemia +  -  -
Hyperbilirubinemia +  -  -
Hyperferritinemia Not  done  -  +
Hemophagocytosis in bone marrow  +  +  +
Hemophagocytosis in other parts  -  +  -